Scientific Program

2022 Abstracts Now Available!

View by visiting the AJT Congress Website.

Full Symposia Details Available


Scientific material will be presented through symposia, oral abstracts, and poster presentations as well as small group conversation-based sessions with experts designed for exploration of both clinical and basic science topics.  

Tips to View the Program

There are many ways to view the ATC 2022 program.  Plan your schedule by viewing the Program Topics & Session Titles that are listed to help shape your experience!

  1. Download the Registration Brochure View Program Topics, Presentation Titles, & Presenter Names.
  2. Download Schedule at a glance View the Program Schedule by Day and Time Block.
  3. AJT Congress Abstract Site View Abstract Text, Figures, Graphs.

All programs listed are included with registration.

Time Zone Schedule of Program – Eastern Time Zone

The program schedule is built in Eastern Time Zone.


Daily Schedule

Saturday, June 4, 2022

 
In-Depth Symposia

9:30 AM - 12:00 PM ET

Presentations with Question & Answers

Topic & Session Titles:

  • Kidney: Overcoming Traditional Paradigms in Living Donation – When do we Loosen the Belt?
  • Liver: Living Donor Liver Transplantation in the United States 2021 and Beyond
  • Heart & Lung: Donation After Circulatory Death in Heart & in Lung Transplantation – The When, How and Why?
  • Pharmacy: Transplant Pharmacy in 2022 and Beyond: Strategies to Optimize Performance Metrics and Characterize Pharmacist Activities Across the Transplant Continuum
  • ID: Deep Dive Into Transplant Infectious Diseases
  • Other: Summary of the Findings and Recommendations of the 2019 AST Consensus Conference “Pre-Existing Malignancy and Transplantation”
  • Pediatric: Pediatric to Adult Transition of Care - A Task Worthy of Sisyphus?
  • Professional Development & Advanced Practice Provider: Building Tomorrow’s Leaders – A Path Towards a Leadership Role in Transplantation
  • Basic Science & Translational: Aging
 
Break

12:00 - 12:30 PM ET

 
Sponsored Satellite Symposia

12:30 - 1:30 PM ET

 
Break

1:30 - 2:00 PM ET

 
Late Breaking Clinical Trials Abstract Session

2:00 - 3:00 PM ET

 
Break

3:00 - 3:15 PM ET

 
Meet the Expert Sessions

3:15 - 4:00 PM ET 

Presentations with Question & Answers

Topic & Session Titles:

  • Heart: Consideration of Durable MCS Versus Transplantation in Patients Who are Marginal Transplant Candidates
  • Pediatric: Technically Challenging Cases in Pediatric Abdominal Transplantation: Pearls and Pitfalls
  • Professional Development: Looking Under the Hood of High Impact Research: From Idea to AJT Publication
  • Lung: CLAD: It's a New World: Or Is It?
  • Public Policy & Regulatory: The Great Debate: Islets as a Biologic or an Organ for Transplant. Time for an Answer!
  • ID: Learning Through Lived Experience: The Value of Perspectives from Transplant Recipient-Physicians
  • Other: The Current State of Cancer & Transplantation
  • Kidney: POV: The Living Donor Experience
  • Advanced Practice Provider: Improving Access and Ensuring Successful Outcomes in the Undocumented Immigrant Pediatric Population

 
Break

4:00 - 4:30 PM ET

 
Meet the Expert Sessions

4:30 - 5:15 PM ET

Presentations with Question & Answers

Topic & Session Titles:

  • Professional Development: Promoting Equity for Women in Healthcare
  • ID: When Standard Therapies Fail: Turn to Phage and Adopt T Cell Therapies
  • Liver: Finding Room to Breathe: Liver Disease and Transplantation in Cystic Fibrosis
  • Pancreas & Liver: 3D Bioprinting – Perspectives of Clinical Application
  • Psychosocial & Ethics: Galvanizing the Transplant Professional Community to Address Racism and Racial Disparities in Transplantation
  • Pediatric: Persistent Epstein-Barr Virus infection: Will the Despair Ever Dissipate?
  • Other: The Recipient Experience: Real World Challenges POV 
  • Advanced Practice Provider: When the Provider Becomes the Patient: Lessons Learned as a Transplant Recipient and Donor

 
Break

5:15 - 5:30 PM ET

 
Poster Session A 

5:30 - 7:00 PM ET

Poster Session A Presenters in Attendance.

  • Administrative: Quality Assurance Process Improvement & Regulatory Issues
  • Basic Science / Immunology: Acute Rejection
  • Basic Science / Immunology: Tissue Engineering and Regenerative Medicine
  • Basic Science / Immunology: Ischemia Reperfusion
  • Basic Science / Immunology: Chronic Organ Rejection
  • ID: All Infections (Excluding Kidney & Viral Hepatitis) I
  • Kidney: Deceased Donor Allocation
  • Kidney: Deceased Donor Selection
  • Kidney: Cardiovascular and Metabolic Complications
  • Kidney: Living Donor: Long Term Outcomes
  • Kidney: Pediatrics
  • Kidney: Complications: Immune Mediated Late Graft Failure
  • Liver: Retransplantation and Other Complications
  • Liver: Recipient Selection
  • Liver: Expanding the Donor Pool (Liver: MELD Allocation / Donor Issues)
  • Organ Inclusive: Non-Organ Specific: Organ Preservation / Ischemia Reperfusion Injury
  • Clinical Trials
 
Poster Chats Session 1

5:30 - 7:00 PM ET

  • Kidney 1
  • Basic 1

Sponsor Networking

5:30 - 7:00 PM ET

Join your fellow colleagues in Exhibit Hall C & D, Level 2 for the opening reception with sponsors.  Beverages and Hors D’oeuvres will be served. 

 
ATC's Women's Networking Event

Supported by CareDx

6:30 - 8:00 PM ET

Discussion, Question and Answer sessions

Join your fellow peers for ATC’s Women’s Networking Event. This networking event will go beyond the curriculum to discuss strategies to achieve personal and professional success.

 

Sunday, June 5, 2022

 
IMPACT Sessions

7:00 - 8:00 AM ET

Presentations with Question & Answers

Topic & Session Titles:

  • Kidney: Should Frailty and Cognition Status Determine Transplant Eligibility
  • Kidney: Interpreting Living Donor Kidney Function at Evaluation: One Size Fits All OR Individualized Thresholds/GFR Cut Offs for Age, Gender and Size?
  • Liver: Substance Use Among Transplant Candidates: Challenges Faced in Pre-transplant Evaluation and Post-transplant Care
  • Heart: Donor-Derived Cell Free - DNA – Thinking Outside of the Box: Lessons to be Learned
  • Pediatric: Is Obesity a Contraindication to Transplantation in Children or Can it be Managed?
  • Basic Science / Immunology: Harnessing the Potential of Tregs: Regulating the Regulators
  • Translational: Stem Cells in Transplantation
  • ID: Safe Living After Transplant
  • Pharmacy: Co-Stimulatory Inhibitor Pearls and Perplexities
  • Psychosocial & Ethics: Shared Decision Making after Failing Transplants
  • Public Policy & Regulatory: Organ Allocation in the U.S.: A New Path Forward
  • Advanced Practice Provider: Stepping into Research: Advancing a Clinical Question to Publication
 
Break

8:00 - 8:25 AM ET

 
Plenary Oral Abstract Session 1

8:25 - 9:30 AM ET

Presentations with Question & Answers

Multiple Topics Highly Rated Abstracts Submitted to ATC 2022

 
Sponsor Networking

9:30 - 10:00 AM ET

Join your fellow colleagues in Exhibit Hall C & D, Level 2 for networking with sponsors.  Beverages will be served.  

 
Product Theater

9:30 - 10:00 AM ET

  • Sponsored by CareDx

This product theater is not part of the ATC official educational program and the session and content is not endorsed by ATC.

This is open to all registered ATC attendees and there is no separate registration fee to attend.

 
AST Presidential Introduction & Address

10:00 - 10:30 AM ET

 
AST Achievement Awards & Lifetime Achievement Awards

10:30 - 11:30 AM ET

 
Paul I. Terasaki State of the Art Lecture 

11:30 AM - 12:00 PM ET

United States' Role in Global Transplantation
Nancy Ascher, MD, PhD

Sponsored by the Terasaki Innovation Center

 
Break

12:00 - 12:30 PM ET

 
Sponsored Satellite Symposia

12:30 - 1:30 PM ET

 
Break

1:30 - 2:00 PM ET

 
IMPACT Sessions

2:00 - 3:00 PM ET

Presentations with Question & Answers

Topic & Session Titles:

  • Kidney: Recurrent Glomerular Disease After Kidney Transplantation: Application of Genetic Testing, Risk stratification, Preventing Strategies and Novel Therapeutics for Disease Recurrence
  • Kidney: Sodium-Glucose Cotransporter-2 (SGLT-2) Inhibitors: Are Gliflozins a Game Changer for Improving Post-Transplant Outcomes?
  • Liver: Transplant Oncology – Expanding Indications for Liver Transplant
  • Heart & Lung: Obtaining the Transplant Dream - Can We Tackle the Contraindications in Heart and Lung Transplant Candidates?
  • Heart: Use of mTORs in Heart Transplantation - Who and When and How
  • Psychosocial & Ethics: Cannabinoids are Here to Stay: It is Time to Understand Their Harms and Benefits in End-Stage Organ Disease and Transplantation
  • Translational: Advances in Liver Regeneration
  • ID: Updates and Controversies in Cytomegalovirus
  • Pharmacy: Navigating the Role of Biologics and Biosimilars in Solid Organ Transplant Recipients
  • Advanced Practice Provider: Advanced Practice Providers in Transplant Leadership Roles
  • Organ Allocation: Strategies for Reducing Blood Loss During Transplant and Serving the Transfusion-Free Community
 
Late Breaking COVID-19 Abstract Session

2:00 - 3:00 PM ET


Sponsor Networking

3:00 - 3:30 PM ET

Join your fellow colleagues in Exhibit Hall C & D, Level 2 for networking with sponsors.  Beverages and light snacks will be served.  

 
Product Theater

3:00 - 3:30 PM ET

Optimizing Outcomes in Transplant Infectious Disease Management, Sponsored by Eurofins Transplant Diagnostics

This product theater is not part of the ATC official educational program and the session and content is not endorsed by ATC.

This is open to all registered ATC attendees and there is no separate registration fee to attend.

 
Focus in Transplantation

Basic Science / Immunology: OMICS in Transplantation

3:30 - 7:00 PM ET

Presentations with Question & Answers

 
Rapid Fire Oral Abstract Sessions

3:30 - 5:00 PM ET

Presentations with Question & Answers

Multiple Topics of Abstracts Submitted to ATC 2022

  • Kidney: Deceased Donor Allocation
  • Kidney: Psychosocial
  • Kidney: Cardiovascular and Metabolic Complications I
  • Liver: Hepatocellular Carcinoma and Other Malignancies
  • Lung: Infectious Considerations for Lung Transplantation
  • ID: Cytomegalovirus and other Herpes Viruses
  • ID: PTLD and Malignancies
  • Organ Inclusive: Disparities to Outcome and Access to Healthcare
  • Basic Science / Immunology: Xenotransplantation
  • Basic Science / Immunology: Histocompatibility and Endothelial / Lymphatic Cell Biology
  • Late Breaking: Clinical
 
Sponsor Networking 

5:00 - 5:30 PM ET

Join your fellow colleagues in Exhibit Hall C & D, Level 2 for networking with sponsors.  Beverages snacks will be served. 

 
Rapid Fire Oral Abstract Sessions

5:30 - 7:00 PM ET

Presentations with Question & Answers

Multiple Topics of Abstracts Submitted to ATC 2022

  • Kidney: Living Donor: Long Term Outcomes
  • Kidney: Pediatrics
  • Kidney: Complications: Chronic Antibody Mediated Rejection & Immune Mediated Late Graft Failure
  • Liver: Cirrhosis: Complications, Portal Hypertension and Renal Management
  • Liver: Surgery innovative Techniques Including Living Donor
  • Heart and VADS: All Topics I
  • Pharmacy: Non-Organ Specific: Clinical Pharmacy / Transplant Pharmacotherapy
  • ID: COVID-19 Infections Part 1: All Organs
  • Basic Science / Immunology: Immunosuppression and Tolerance: Preclinical and Translational Studies
  • Basic Science / Immunology: Cellular / Islet Therapies and Tissue Engineering
  • Basic Science / Immunology: Innate Immunity, Chemokines, Cytokines, and Complement
 
ASTS Town Hall

5:30 - 7:00 PM ET

 
Poster Session B

7:00 - 8:00 PM ET

Poster Session B Presenters in Attendance.

  • Basic Science / Immunology: Antigen Presentation / Allorecognition / Dendritic Cells
  • Basic Science / Immunology: Vascular, Lymphatic, Stromal and Parenchymal Cell Biology
  • Basic Science / Immunology: Co-Stimulation in Alloreactive Effector and Regulatory Responses
  • Basic Science / Immunology: Histocompatibility and Immunogenetics
  • Basic Science / Immunology: Machine Perfusion and Organ Rehabilitation - Basic
  • VCA
  • ID: All Infections (Excluding Kidney & Viral Hepatitis) II
  • ID: Kidney Infectious Non-Polyoma & Non-Viral Hepatitis
  • ID: PTLD: All Topics
  • Pharmacy I
  • Kidney: Immunosuppression: Desensitization
  • Kidney: Living Donor: Other
  • Kidney: Acute Antibody Mediated Rejection
  • Kidney: Paired Exchange
  • Liver: Kidney Issues in Liver Transplantation
  • Liver: Immunosuppression and Rejection
  • Liver: Hepatocellular Carcinoma and Other Malignancies
  • Liver: MELD Allocation
  • Heart and VADs: All Topics
  • Pancreas and Islet: All Topics
  • Organ Inclusive: Non-Organ Specific: Disparities to Outcome and Access to Healthcare
  • COVID-19
 
Poster Chats Session 2

7:00 - 8:00 PM ET

  • ID
  • Basic 2

Sponsor Networking

7:00 - 8:00 PM ET

Join your fellow colleagues in Exhibit Hall C & D, Level 2 for networking with sponsors.  Beverages and light snacks will be served.  

 

Monday, June 6, 2022

 
IMPACT Sessions

7:00 - 8:00 AM ET

Presentations with Question & Answers

Topic & Session Titles:

  • Kidney: Tissue is the Issue: Kidney Procurement Biopsy- Should We Even Think About It?
  • Kidney: GFR After Living Donor Nephrectomy: It’s Donation Not Chronic Kidney Disease!
  • Liver: No Longer ‘Hype’? Progress in Implementing Non-Invasive Biomarkers in Liver Transplant Immunosuppression Management
  • VCA: VCA, Tolerance and Regenerative Medicine
  • Pediatric: Racial and Ethnic Disparities in Pediatric Transplantation
  • Basic Science / Immunology: Visualizing Immune Responses and Rejection
  • Translational: Monitoring Immune Function After Transplantation
  • ID: We Contain Multitudes - Microbiome and Transplant
  • Pharmacy & Liver: Let’s Be Direct: Ultra-short Direct Acting Anti-Viral Prophylaxis to Expand Donor Pool
  • Psychosocial & Ethics: Advancing Transplant Ethics and Psychosocial Research Methods Beyond the 20th Century
  • Basic Science & Discard: B Cells in Transplant Rejection and Tolerance
  • Advanced Practice Provider: Raising the Bar: Success with Alcoholic Hepatitis Transplantation
 
Break

8:00 - 8:10 AM ET

 
Plenary Oral Abstract Session 2

Honoring former AST President Barbara Murphy, MD

8:10 - 9:15 AM ET

Presentations with Question & Answers

Multiple Topics Highly Rated Abstracts Submitted to ATC 2022

 
Sponsor Networking

9:15 AM - 9:45 AM ET

Join your fellow colleagues in Exhibit Hall C & D, Level 2 for networking with sponsors.  Beverages will be served.  

 
Product Theater

9:15 - 9:45 AM ET

  • Protection Onboard: A Clinical Approach to Preventing COVID-19 in At-Risk Patients, Sponsored by AstraZeneca
  • Quest Advanced Specialized Transplant Services: Enhanced Infectious Disease Testing, Sponsored by Quest Diagnostics

These product theaters are not part of the ATC official educational program and the sessions and content are not endorsed by ATC.

These are open to all registered ATC attendees and there is no separate registration fee to attend.

 
ASTS Presidential Introduction & Address

9:45 - 10:15 AM ET

 
ASTS Research Grants & Pioneer Award

10:15 - 11:15 AM ET

 
Innovations in Transplantation 

Clinical Xenotransplantation Updates

11:15 AM - 12:30 PM ET

 
Break

12:30 - 12:45 PM ET

 
Sponsored Satellite Symposia

12:45 - 1:45 PM ET

 
Break

1:45 - 2:00 PM ET

 
IMPACT Sessions

2:00 - 3:00 PM ET

Presentations with Question & Answers

Topic & Session Titles:

  • Kidney: What's the Optimal Individualized Approach to Managing a Patient with a Declining or Failed Kidney Allograft?
  • Liver: Biomarkers for Liver Assessment in Machine Perfusion
  • Liver: Heart Liver Transplant: Indications
  • Professional Development: Burnout in Transplant Teams
  • Basic Science / Immunology: SARS-CoV2 Immunity and Pathogenesis
  • Basic Science / Immunology: Transformative Multidisciplinary Research Through Transplant Declined Human Organs
  • Translational: Desensitization – Translational Science
  • ID: Shot Topic Debate: Vaccine Mandates for Transplant Candidates
  • Pharmacy & Advanced Practice Provider: Telehealth in Transplant: The New Paradigm
  • Other: The Future of Transplant is...
  • Other: Ensuring Equity in Transplant: Priorities for National Expansion of Best Practices
  • COVID-19: Perspectives on Consistency and Safety in Organ Donation While Navigating COVID-19 Surges: Optimal Utilization of Organs from SARS-CoV-2-positive Donors

 
Sponsor Networking

3:00 - 3:30 PM ET

Join your fellow colleagues in Exhibit Hall C & D, Level 2 for networking with sponsors.  Beverages and light snacks will be served. 

 
Product Theater

3:00 - 3:30 PM ET

  • Sponsored by CareDx
  • Costimulation Based Immunosuppression: Challenges and Opportunities, Sponsored by Veloxis Pharmaceuticals

These product theaters are not part of the ATC official educational program and the sessions and content are not endorsed by ATC.

These are open to all registered ATC attendees and there is no separate registration fee to attend.

 
Focus in Transplantation 

Translational - Role of Biomarkers in Immune Profiling

3:30 - 7:00 PM ET

Presentations with Question & Answers

 
Rapid Fire Oral Abstract Sessions

3:30 - 5:00 PM ET

Presentations with Question & Answers

Multiple Topics of Abstracts Submitted to ATC 2022

  • Kidney: Deceased Donor Selection I
  • Kidney: Acute Cellular Rejection
  • Kidney: Cardiovascular and Metabolic Complications II
  • Liver: Expanding the Donor Pool (MELD Allocation / Donor Issues)
  • Heart and VADS: All Topics II
  • ID: COVID-19 Infections Part 2: All Organs
  • ID: Kidney: Polyoma Infections
  • Public Policy & Regulatory: Non-Organ Specific: Public Policy & Allocation
  • Basic Science / Immunology: Ischemia Reperfusion
  • Basic Science / Immunology: B-cell / Antibody / Autoimmunity
  • Late Breaking: Basic / Translational
 
Sponsor Networking

5:00 - 5:30 PM ET

Join your fellow colleagues in Exhibit Hall C & D, Level 2 for networking with sponsors.  Beverages will be served. 

 
Rapid Fire Oral Abstract Sessions

5:30 - 7:00 PM ET

Presentations with Question & Answers

Multiple Topics of Abstracts Submitted to ATC 2022

  • Kidney: Technical
  • Kidney: Complications: Non-Immune Mediated Late Graft Failure
  • Kidney: Health Equity and Access I
  • Liver: MELD Allocation and Large Data
  • Liver: Pediatrics
  • Lung: Early and Late Outcomes in Lung Transplantation
  • Small Bowel: Intestinal Transplantation and Rehabilitation
  • ID: Transplant Infectious Diseases: All Organs
  • Basic Science / Immunology: Machine Perfusion and Organ Rehabilitation - Basic
  • Basic Science / Immunology: Acute Rejection
  • Basic Science / Immunology: Immunoregulation and Tolerance
 
AST Town Hall

5:30 - 8:00 PM ET

 
Poster Session C

7:00 - 8:00 PM ET

Poster Session C Presenters in Attendance

  • Basic Science / Immunology: B-cell / Antibody / Autoimmunity
  • Basic Science / Immunology: Innate Immunity; Chemokines, Cytokines, Complement
  • Basic Science / Immunology: Treg / Other Regulatory Cell / Tolerance
  • Basic Science / Immunology: Immunosuppression & Tolerance: Preclinical & Translational Studies
  • Basic Science / Immunology: Biomarkers: -omics and Systems Biology
  • Basic Science / Immunology: Immunometabolism
  • Public Policy & Regulatory: Non-Organ Specific: Public Policy & Allocation
  • ID: All Infections (Excluding Kidney & Viral Hepatitis) III
  • ID: Kidney: Polyoma
  • Kidney: Psychosocial
  • Kidney: Immunosuppression: Induction Therapy
  • Kidney: Technical
  • Kidney: Chronic Antibody Mediated Rejection
  • Kidney: Recurrent Kidney Disease & Genetics
  • Liver: Cirrhosis - Portal Hypertension and Other Complications
  • Liver: Surgery Innovative Techniques
  • Liver: Pediatrics
  • Lung: Transplantation
  • Organ Inclusive: Non-PTLD / Malignancies
  • Organ Inclusive: Surgical Issues (Open, Minimally Invasive): All Organs
 
Poster Chats Session 3

7:00 - 8:00 PM ET

  • Kidney 2
  • Organ Inclusive

Sponsor Networking

7:00 - 8:00 PM ET

Join your fellow colleagues in Exhibit Hall C & D, Level 2 for networking with sponsors.  Beverages and light snacks will be served.  

 

Tuesday, June 7, 2022

 
IMPACT Sessions

7:00 - 8:00 AM ET

Presentations with Question & Answers

Topic & Session Titles:

  • Kidney: Kidney Paired Donation First and Foremost: Decoupling All Donor and Recipient Pairs Should Become Standard of Care
  • Kidney: A2 to B: Antibodies, Testing, and Best Practices
  • Liver: Personalized Management of Cardiovascular Disease in Liver Transplant Recipients
  • VCA: Candidates and Recipients of VCA Procedures: An Update from Ongoing Studies
  • Pediatric: Pediatric Solid Organ Transplantation: Unique Surgical Considerations
  • Basic Science / Immunology: The Microbiome in Immunomodulation and Transplantation
  • HLA: Should Transplant Programs Routinely Test for Non-HLA Antibodies?
  • ID: The Donor Had What???
  • Other: From Cause to Care Plan: Assessment and Management of Post-Transplant Delirium
  • Small Bowel: New Frontiers in Intestine Transplant
  • Women's Health: Solving the Sex-based Disparity in Access to Liver Transplant: Pragmatic Nudge vs. Comprehensive Overhaul
  • Advanced Practice Provider: Unique Case Studies Presented by Advanced Practice Providers
 
Break

8:00 - 8:25 AM ET

 
Plenary Oral Abstract Session 3

8:25 - 9:30 AM ET

Presentations with Question & Answers

Multiple Topics Highly Rated Abstracts Submitted to ATC 2022

 
Sponsor Networking

9:30 - 10:00 AM ET

Join your fellow colleagues in Exhibit Hall C & D, Level 2 for networking with sponsors.  Beverages will be served.  

 
Product Theater

9:30 - 10:00 AM ET

Sponsored by CareDx

This product theater is not part of the ATC official educational program and the session and content is not endorsed by ATC.

This is open to all registered ATC attendees and there is no separate registration fee to attend.

 
IMPACT Sessions

10:00 - 11:00 AM ET

Presentations with Question & Answers

Topic & Session Titles:

  • Kidney: APOL1 Risk Variant Assessment in Living Kidney Donor Evaluation
  • Kidney: Small Steps That Can Made A Big Impact: Decreasing The Burden Of Chronic Antibody Mediated Rejection With The Tools We Have
  • Liver: Can We Break the Barriers in Access and Utilization of LDLT in Special Populations?
  • Heart: Are Destination LVAD the Only Type of VAD Left? Debate in Light of Recent Update to CMS Coverage Policy and UNOS Reclassification
  • Pediatric: Sickle Cell Disease, End Organ Damage, and Transplantation
  • Basic Science / Immunology: Bioengineering Better Transplant Outcomes
  • Translational: Costimulation Blockade
  • ID: Stump the Stars
  • Pharmacy: Immuno Bill: Past, Present and Future Directions
  • Lung & Liver: Bridge to Transplant 2022, The Lung Transplant Candidate on Acute Life Support
  • Psychosocial & Ethics: Ethical Dilemmas
  • Advanced Practice Provider: Groundbreaking Research Led by Advanced Transplant Providers
 
Break

11:00 - 11:15 AM ET

 
AJT Awards & Update

11:15 - 11:45 AM ET

 
Thomas Starzl State of the Art Lecture 

11:45 AM - 12:15 PM ET

Creating the 1st Life-Saving Xenoheart Transplanted into a Person
Martine Rothblatt, PhD

 
Break

12:15 - 12:45 PM ET

 
Sponsored Satellite Symposia

12:45 - 1:45 PM ET

 
Break

1:45 - 2:00 PM ET

 
IMPACT Sessions

2:00 - 3:00 PM ET

Presentations with Question & Answers

Topic & Session Titles:

  • Kidney: Biomarkers in Glomerular Diseases: Exploring Utility in Understanding Recurrence Risk and Prognosis Post Transplant
  • Kidney: Long-Term Survival After Kidney Transplantation
  • Liver: To Kidney or Not to Kidney: Lesson Learned
  • Other: Sharing the Sandbox: Combined Thoracic/Abdominal DCD Organ Procurements
  • Small Bowel: Challenges in Allocation for Multivisceral Transplant
  • Pancreas: Wait, Did You Say This is a Pancreas Donor? Time to Get Comfortable Doing More Pancreas Recoveries
  • Basic Science / Immunology: Immunometabolism in Transplantation
  • Translational: CRISPR Technologies in Transplantation
  • HLA: New Approaches to HLA Matching and Unacceptable Antigen Determination for Solid Organ Transplantation
  • Pediatric & Liver: Should Surgeons Travel to the Graft? Or Should Grafts Travel to the Surgeon? In Situ Split versus Ex Situ Split for Pediatric Liver Transplantation
  • Advanced Practice Provider: Expanding the Advanced Transplant Provider Pool: Orientation, Training, and Retention
  • COVID-19: COVID-19 in Specific Transplant Populations
 
Sponsor Networking

3:00 - 3:30 PM ET

Join your fellow colleagues in Exhibit Hall C & D, Level 2 for networking with sponsors.  Beverages and light snacks will be served. 

 
Product Theater

3:00 - 3:00 PM ET

Harnessing the Power of Immune Tolerance in Living-Donor Kidney Transplant: FCR001: an Investigational Allogeneic Cell Therapy, Sponsored by Talaris Therapeutics

This product theater is not part of the ATC official educational program and the session and content is not endorsed by ATC.

This is open to all registered ATC attendees and there is no separate registration fee to attend.

 

 
Rapid Fire Oral Abstract Sessions

3:30 - 5:00 PM ET

Presentations with Question & Answers

Multiple Topics of Abstracts Submitted to ATC 2022

  • Kidney: Deceased Donor Selection II
  • Kidney: Immunosuppression: Desensitization & Acute Antibody Mediated Rejection
  • Kidney: Immunosuppression
  • Liver: Recipient Selection
  • Pancreas and Islet: All Topics
  • Organ Inclusive: Surgical Issues: Donor and Recipient
  • Psychosocial & Ethics: Psychosocial and Treatment Adherence
  • VCA
  • Basic Science / Immunology: Biomarkers: Clinical Outcomes I
  • Basic Science / Immunology: Biomarkers: -omics and Systems Biology
  • Basic Science / Immunology: Antigen Presentation and Costimulation
 
Year in Review

Most Impactful Papers in Transplant ID

3:30 - 5:00 PM ET

Presentations with Question & Answers

 
Sponsor Networking

5:00 - 5:30 PM ET

Join your fellow colleagues in Exhibit Hall C & D, Level 2 for networking with sponsors.  Beverages will be served. 

 
Rapid Fire Oral Abstract Sessions

5:30 - 7:00 PM ET

Presentations with Question & Answers

Multiple Topics of Abstracts Submitted to ATC 2022

  • Kidney: Living Donor & Paired Exchange
  • Kidney: Recurrent Kidney Disease & Genetics
  • Kidney: Health Equity and Access II
  • Liver: Retransplantation and Other Complications
  • Pharmacy: Non-Organ Specific: Pharmacokinetics / Pharmacogenomics / Drug Interactions
  • Organ Inclusive: Machine Learning, Artificial Intelligence and Social Media in Transplantation
  • ID: Kidney Transplant Infections
  • ID: Viral Hepatitis
  • Basic Science / Immunology: Biomarkers: Clinical Outcomes II
  • Basic Science / Immunology: Chronic Organ Rejection
  • Basic Science / Immunology: Tregs and Tolerance
  • Administrative: Quality Assurance Process Improvement & Regulatory Issues
 
Poster Session D

7:00 - 8:00 PM ET

Poster Session D Presenters in Attendance

  • Basic Science / Immunology: Translational Cellular Therapies: Islet and Stem Cell Transplantation
  • Basic Science / Immunology: Xenotransplantation
  • Basic Science / Immunology: Biomarkers: Clinical Outcomes
  • Psychosocial & Ethics: Psychosocial and Treatment Adherence
  • Psychosocial & Ethics: Non-Organ Specific: Economics & Ethics
  • ID: All Infections (Excluding Kidney & Viral Hepatitis) IV
  • ID: Non-Organ Specific: Viral Hepatitis
  • Pharmacy II
  • Kidney: Acute Cellular Rejection
  • Kidney: Immunosuppression: Novel Regimens and Drug Minimization
  • Kidney: Living Donor: Selection
  • Kidney: Complications: Non-Immune Mediated Late Graft Failure
  • Kidney: Health Equity and Access
  • Liver: Living Donor Liver Transplant and Partial Grafts
  • Organ Inclusive: Deceased Donor Management and Intervention Research
  • Organ Inclusive: Machine Learning, Artificial Intelligence and Social Media in Transplantation
 
Poster Chats Session 4

7:00 - 8:00 PM ET

  • Heart and Lung
  • Liver

Sponsor Networking

7:00 - 8:00 PM ET

Join your fellow colleagues in Exhibit Hall C & D, Level 2 for networking with sponsors.  Beverages and light snacks will be served.  

 

Wednesday, June 8, 2022

 
IMPACT Sessions

7:00 - 8:00 AM ET

Presentations with Question & Answers

Topic & Session Titles:

  • Small Bowel: Advanced Management for Infectious Complications of Intestine/Multivisceral Transplant
  • Public Policy & Regulatory: The Perfusion Revolution
  • Liver: Controversial Indications for Live Donor Liver Transplantation: A Risk Worth Taking?
  • Pancreas: Novel Methodologies to Improve Clinical Outcomes after Islet Cell Auto-transplantation
  • Pediatric & Kidney: Choosing a Best Kidney for Pediatric Recipients to Optimize Long-Term Graft Survival: Is There Such a Thing?
  • Basic Science / Immunology: Non-HLA Antigens and Antibodies
  • Translational: Bioengineering in Transplantation: Where We are and Where are We Going?
  • Other: Frailty Thy Name is “Human”: Lessons Learned and Gaps to Bridge 
  • Administrative: Metrics and Measurement of Transplant Programs: What You Need to Know
  • Women's Health: Safe Sex and Body Image - Can We Do Right by Our Patients? Wellness in Solid Organ Transplant Recipients Across All Age Groups
  • Pharmacy & ID: Putting Brakes on Antifungal Resistance: Antifungal Stewardship and Novel Anti-Fungals
  • Perfusion & Discard: New Avenues of Preventing Discard
 
Break

8:00 - 8:25 AM ET

 
Plenary Oral Abstract Session 4

8:25 - 9:30 AM ET

Presentations with Question & Answers

Multiple Topics Highly Rated Abstracts Submitted to ATC 2022

 
ATC's People's Choice Award

9:30 - 10:00 AM ET

Audience Polling 

Multiple Topics. Audience will Vote on the MOST Impactful Plenary Abstract Presentation.

 
Break

10:00 - 10:15 AM ET

 
Controversies in Transplantation

10:15 - 11:15 AM ET

  • Public Policy & Regulatory: Selflessness or Selfishness: What Philosophy Should Underpin Organ Donor Registration Initiatives?
  • Basic Science & Translational: We Need Car T-cells to Effectively Desensitize High PRA Patients
 
Break

11:15 - 11:45 AM ET

 
What's Hot; What's New

11:45 AM - 12:30 PM ET